|
|
- 2017
舍格伦综合征患者唾液MMP-9表达与组织病理分级相关性研究
|
Abstract:
摘要 目的: 观察基质金属蛋白酶9(MMP-9)在舍格伦综合征病人唾液中的表达情况,分析其与组织病理分级的相关性,探讨唾液中MMP-9水平作为舍格伦综合征特异性标志物的可能性。方法: 采集27例舍格伦综合征患者(实验组)和29例下唇黏液囊肿患者(对照组)的唾液,应用酶联免疫吸附试验(ELISA)检测其MMP-9的表达水平,其中实验组按照病理分级严重程度分为病理分级低的1、2级以及病理分级高的3、4级患者。结果: 实验组患者唾液中MMP-9表达水平高于对照组,两组之间表达水平结果比较差异有统计学意义;病理分级高的舍格伦综合征患者组唾液中MMP-9水平高于病理分级低的患者组,两组比较差异有统计学意义。结论: 唾液中MMP-9表达水平可能成为舍格伦综合征的一项检测指标,并为临床诊治提供参考依据
| [1] | Baldini C, Pepe P, Quartuccio L, et al. Primary Sj gren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients [J]. Rheumatology (Oxford), 2014, 53(5)∶839-844 |
| [2] | 俞洁,章功杰,陈松军,等.糖尿病患者唾液流率与口干相关性研究[J].口腔医学研究杂志, 2016,32(2)∶177-180 |
| [3] | Gandia M, Morales-Espinoza EM, Martin-Gonzalez RM, et al. Factors influencing dry mouth in patients with primary sj gren syndrome: usefulness of the ESSPRI index [J]. Oral Health Manaq, 2014, 13(2)∶402-407 |
| [4] | Yixuan Gong,Uma D.Roles of Matrx Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression [J]. Cancer Res,2014,6(3)∶1298-1327 |
| [5] | Novakovie N, Todorovic T, Rakic M, et al. Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome [J]. Periodontal Res,2014,49(1)∶129-136 |
| [6] | 王璐,李霞.舍格伦综合征口干症的研究进展[J].国际口腔医学杂志,2016,43(3)∶314-317 |
| [7] | Feltsan T, Stanko P, Mracna J. Sj gren’s syndrome in present [J]. Bratisl Lek Listy, 2012,113(8)∶514-516 |
| [8] | 李桐,袁国华,聂敏,等.MMP-9基因敲除小鼠磨牙牙胚中釉原蛋白和成釉蛋白表达的研究[J].口腔医学研究,2016,32(11)∶1117-1121 |
| [9] | Fernando Llambes, Santiago Arias-Herrera, Raul Caffesse, et al. Relationship between diabetes and periodontal infection [J]. World J Diabetes,2015,6(7)∶927-935 |
| [10] | Nocturne G, Virone A, Ng WF, et al. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sj gren’s Syndrome [J]. Arthritis Rheumatol, 2016, 68(4)∶977-985 |
| [11] | Rasmussen A, Ice JA, Li H, et al. Comparison of the American-European Consensus Group Sj gren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort [J]. Ann Rheum Dis, 2014,73(1)∶31-38 |
| [12] | Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sj gren syndrome with rituximab: a randomized trial [J]. Ann Intern Med, 2014, 160(4)∶233-242 |
| [13] | Elise M,Gervais Kara A. Changs in the submandibular salivary gland epithelial cell subpopulations during progression of Sj gren’s syndrome-like disease in the NOD/Shiltj Mouse model [J]. Anat Rec,2015,298(9)∶1622-1634 |
| [14] | Yazisiz V, Behlul A, Basak ST. Expression of podoplanin in minor salivary glands increases in primary Sj gren’s syndrome [J]. J Rheumatol, 2013, 40(12)∶2100-2102 |
